戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              SDD administration significantly downregulated PAR2, IL-
2                                              SDD and next-day discharge cohorts had similar rates of
3                                              SDD was more frequently used among male and younger pati
4                                              SDD was well tolerated, with a low incidence of disconti
5                                              SDD-40 used as an adjunct to SRP resulted in significant
6 s (8.7%), drusen >=63 mum in 9 eyes (39.1%), SDD in 5 eyes (21.7%), cuticular drusen in 1 eye (4.3%)
7 ose flurbiprofen (LDF) alone, 50 mg q.d.; 2) SDD (20 mg b.i.d.) alone; or 3) a combination of SDD plu
8 based catalysts are determined at the M06-2X/SDD|6-311+G(2df,p)//M06-L/SDD|6-31G(d)|MIDI!
9 RF (12.763, 4.763-34.202, P < 0.001, 38.8%), SDD (2.307, 1.003-5.304, P = 0.049, 34.2%), hDC (3.012,
10 re randomly assigned to adopt or not adopt a SDD strategy for 2 alternating 12-month periods, separat
11 a fidelity cost that is mitigated by using a SDD sequence in the palm domain.
12                                 In addition, SDD treatment was accompanied by lower rates of alveolar
13                                   Adjunctive SDD-40 provided significantly greater clinical benefits
14                      In addition, adjunctive SDD is more effective than a placebo in preventing furth
15  and randomized to receive either adjunctive SDD or placebo for 9 months.
16 te sites (baseline PD 4 to 6 mm), adjunctive SDD-40 provided significant clinical benefits compared t
17 conducted to test the efficacy of adjunctive SDD-40 in 266 subjects with periodontitis.
18      Subgingival debridement plus adjunctive SDD reduced deep pockets (> or =7 mm at baseline) by an
19  subsets of the study population, adjunctive SDD significantly reduced serum biomarkers of bone resor
20 D were greater following SRP with adjunctive SDD than SRP with placebo, achieving statistical signifi
21 th 9 was significantly lower with adjunctive SDD than with adjunctive placebo (P<0.05).
22 D were significantly greater with adjunctive SDD than with adjunctive placebo at 3, 6, and 9 months (
23 toreceptor reflectivity and intact RPE after SDD regression should be seen in the larger context of o
24 al debridement with a host-modulating agent, SDD, provides clinically and statistically significant b
25 Among those with early and intermediate AMD, SDD prevalence was 49% and 79%, respectively.
26 ificant differences between intermediate AMD/SDD (P < .005), and intermediate AMD/GA (P < .005).
27 scribe a framework for the development of an SDD program.
28 M presence (odds ratio 832.9, P < 0.001) and SDD presence (odds ratio 9.42, P = 0.017).
29 r CVI compared with both LVM (P = 0.001) and SDD subgroups (P < 0.001).
30 se in GCF, with much less MMP-1 and -13, and SDD reduced the odds of elevated MMP-8 by 60% compared t
31 lar proportion of RIT variability as age and SDD.
32 and cover on LDD frequency, LDD distance and SDD distance in North America from 1961 to 2015.
33 icant proportion of iAMD (DV, IHRF, hDC, and SDD), a thin DLS and cRORA in the fellow eye were associ
34  values were found in eyes with both HRF and SDD (40.0 [40-40] minutes).
35 common than previously reported, and LDD and SDD may be distinct processes rather than two outcomes o
36 dge, this is the first evidence that LDD and SDD may be separate processes in an avian species, and s
37 relates of distance differed between LDD and SDD movements.
38 not directly correlated with drusen load and SDD location.
39 bitory process is either lost or masked, and SDD facilitation predominates at nondepressed synapses.
40 s with adaptations to ecology monitoring and SDD administration.Trial Registration: ISRCTN40310490 Re
41 ne group: ligature-induced periodontitis and SDD treatment.
42 vulnerable to progressive periodontitis, and SDD may modify that risk.
43  outer segments and RPE apical processes and SDD in eyes with AMD, slower dark adaptation might be re
44 mortality was 25.4% and 24.1% during SOD and SDD, respectively (adjusted odds ratio, 0.96 [95% CI, 0.
45 5.9% and 4.6% of the patients during SOD and SDD, respectively (odds ratio, 0.77 [95% CI, 0.65-0.91];
46 in the clinical outcome analysis for SOD and SDD, respectively.
47                                  The ULD and SDD mediate a critical interaction with IkappaBalpha tha
48  acute appendicitis undergoing appendectomy, SDD is not associated with an increase in 30-day hospita
49  an earlier analysis of data from Australia, SDD did not result in a lower incidence of in-hospital d
50  (M06/SDD-6-311G(d,p)-IEFPCM(acetone)//B3LYP/SDD-6-31G(d)) predict that the product distribution is c
51                DFT (B3LYP-D/Def2-QZVP//B3LYP/SDD:6-31+G(d)) predicts that the alkylation mechanism fo
52  interest overlying and in 5 located between SDD or conventional drusen with the same retinal eccentr
53 S(18) was significantly correlated with both SDD (B: -0.32, P = .047) and FD(6mm) (B: -0.473, P = .00
54 S(18) was significantly correlated with both SDD (beta: -0.32, P = .047) and FD(6mm) (beta: -0.473, P
55 genase activity was significantly reduced by SDD treatment relative to placebo based on intent-to-tre
56 ecause local studies more frequently capture SDD within study areas.
57  of validating and implementing new cefepime SDD criteria, we evaluated the performances of Vitek 2,
58 ontrol/intermediate AMD (P < .0005), control/SDD (P < .0005), control/GA (P < .0005), and intermediat
59                                   Severe DD (SDD) was defined by >=3/four abnormal parameters (medial
60 ethods (selective digestive decontamination [SDD], acidification of gastric content, early enteral fe
61                          In sites delivering SDD, the majority (98%) of children received at least on
62 r = 1 microg/ml; susceptible dose dependent (SDD), 2 microg/ml; and resistant (R), > or = 4 microg/ml
63 /ml (>or=17 mm); susceptible dose dependent (SDD), MIC of 2 microg/ml (14 to 16 mm); and resistant (R
64 sceptible (S) or susceptible-dose dependent (SDD).
65 or E. faecium, a susceptible dose-dependent (SDD) breakpoint of <=4 mug/mL was established based on a
66  codified in new susceptible dose-dependent (SDD) breakpoints promulgated by the Clinical and Laborat
67 andards define a susceptible-dose-dependent (SDD) category for certain organisms and drug combination
68 ptic facilitation [spike duration-dependent (SDD) facilitation], particularly at nondepressed synapse
69 to 32 microg/ml (susceptible dose-dependent [SDD]), or >/=64 microg/ml (resistant) and 10 isolates wi
70      Eyes with subretinal drusenoid deposit (SDD) had reduced PWS centrally, particularly at inferior
71 predominantly subretinal drusenoid deposits (SDD) and 3 without SDD.
72               Subretinal drusenoid deposits (SDD) and HRF were detected on OCT volumes.
73 0 eyes (37%), subretinal drusenoid deposits (SDD) in 8 eyes (29.6%), cuticular drusen in 2 eye (7.4%)
74  19 eyes with subretinal drusenoid deposits (SDD) vs 47 eyes without SDD, rod-mediated dark adaptatio
75 h and without subretinal drusenoid deposits (SDD), using swept-source optical coherence tomography (S
76 46.7%) having subretinal drusenoid deposits (SDD).
77 , 19 AMD with subretinal drusenoid deposits [SDD], 20 geographic atrophy [GA]) and 23 age-matched con
78  (also termed subretinal drusenoid deposits, SDD), which are located above the RPE.
79 n juvenile Aplysia: homosynaptic depression, SDD facilitation, and SDI facilitation.
80  dimethyl dithiocarbamate (SDD), the derived SDD-Ni catalyst exhibits >95% Faradaic efficiency for H(
81                      Real-wastewater-derived SDD-Ni catalysts showed similar performance and sustaine
82                              We now describe SDD effects on biomarkers of collagen degradation and bo
83 11.58 keV, a silicon drift chamber detector (SDD) detector, and pure element reference standards.
84 h a high-performance silicon drift detector (SDD) and two-dimensional/three-dimensional (2D/3D) scann
85                    Study eyes that developed SDD during follow-up demonstrated higher rates of RIT pr
86 ults have suggested that same-day discharge (SDD) after appendectomy is safe and does not result in h
87 here are limited data on same-day discharge (SDD) after LAAC.
88 monstrated safety of the same-day discharge (SDD) after percutaneous coronary intervention (PCI), upt
89  driven to a move toward same day discharge (SDD) following uncomplicated percutaneous coronary inter
90 egarding the outcomes of same-day discharge (SDD) PCI and to describe a framework for the development
91 hesized that social developmental disorders (SDD) like autism, Asperger's disorder and the social-emo
92  frequently than shorter-distance dispersal (SDD).
93 oach termed subtracted differential display (SDD) to identify genes whose expression is regulated by
94 ields using sodium dimethyl dithiocarbamate (SDD), the derived SDD-Ni catalyst exhibits >95% Faradaic
95 tations in the scaffold dimerization domain (SDD) of TBK1 can cause the loss of kinase activity due t
96 d a C-terminal scaffold/dimerization domain (SDD).
97  alpha-helical scaffold/dimerization domain (SDD).
98           Subantimicrobial dose doxycycline (SDD) has been used as an adjunct in periodontal treatmen
99 safety of subantimicrobial dose doxycycline (SDD) in 128 postmenopausal osteopenic females with moder
100 hown that subantimicrobial dose doxycycline (SDD) is of clinical benefit in the treatment of chronic
101  a 2-year subantimicrobial-dose doxycycline (SDD) regimen (double-masked, placebo-controlled clinical
102 us study, subantimicrobial dose doxycycline (SDD) significantly improved clinical parameters associat
103 rted that subantimicrobial-dose doxycycline (SDD) significantly reduced serum bone-resorption biomark
104 ration of subantimicrobial dose doxycycline (SDD) to chronic periodontitis (CP) patients has repeated
105 djunctive subantimicrobial dose doxycycline (SDD) with scaling and root planing leads to improved cli
106 ment with subantimicrobial dose doxycycline (SDD), 20 mg bid, exerted an antimicrobial effect on the
107 egimen of subantimicrobial dose doxycycline (SDD; 20 mg twice a day) was evaluated in postmenopausal
108  trial of subantimicrobial dose doxycycline (SDD; 20 mg two times a day).
109 djunctive subantimicrobial dose doxycycline (SDD; 20 mg, twice daily) provides significant clinical b
110 ated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women signi
111 DD formulation containing 40 mg doxycycline (SDD-40) to be taken once daily has been developed.
112  and safety of subantimicrobial doxycycline (SDD) in 128 postmenopausal osteopenic women with moderat
113  of adjunctive subantimicrobial doxycycline (SDD) or placebo.
114  the free-standing screw-dislocation-driven (SDD) GaSe thin film synthesized by molecular beam epitax
115 ination) of these two host-modulating drugs (SDD plus low-dose NSAID) to CP patients, on selected neu
116 creased 7% per month (95% CI, 1%-13%) during SDD (P = .02) and 4% per month (95% CI, 0%-8%) during SO
117 evalence was 5.6% (95% CI, 4.6%-6.7%) during SDD and 11.8% (95% CI, 10.3%-13.2%) during SOD (P < .001
118 TP showed a similar pattern of change during SDD treatment, and GCF collagenase activity and ICTP wer
119 rianal swabs were significantly lower during SDD compared with SOD; for aminoglycoside resistance, av
120 me considering water supply-demand dynamics (SDD), and compare it with soil-moisture-based irrigation
121                           One group of eight SDD subjects performed normally on all tests of face per
122 e units were randomized to administer either SDD or SOD.
123  visit and were randomized to receive either SDD 20 mg bid or placebo bid for 9 months.
124 5% confidence interval) 2.69 (2.19-3.32) for SDD and 1.73 (1.49-2.02) for >=MDD].
125                                 Criteria for SDD presence were identification on >/=1 en face modalit
126 icrog/ml doxycycline plates at 24 months for SDD versus placebo, the percentage that was clinically r
127                        By using CFP only for SDD detection per the AREDS protocol, prevalence of SDD
128                       GCF was collected from SDD- and placebo-treated PM subjects (n=64 each) at the
129  related to different proximate factors from SDD, including a lack of sex-bias in LDD, suggest that L
130 did not differ between the treatment groups (SDD: 79% to 76%; placebo: 83% to 70%; P = 0.2).
131     Of the 20 981 patients, 4662 (22.2%) had SDD and 16319 (77.8%) were discharged within 1 or 2 days
132        Seventy-two of 190 (38%) patients had SDD, and 118 of 190 (62%) had non-SDD.
133 e features, including high-central DV, IHRF, SDD, hDC, thin DLS, and cRORA in the fellow eye, were as
134                                 One impaired SDD subgroup had poor perception of facial structure but
135                         A definitive cRCT in SDD to prevent HCAIs in critically ill children is feasi
136 t.We conclude that the social disturbance in SDD does not invariably lead to impaired face recognitio
137 to 2013, there has been a modest increase in SDD after PCI.
138 der interest in healthcare systems slower in SDD adoption.
139 eatures and the fine structure of individual SDD lesions identified at baseline were examined by AOSL
140  < .001; I(2) = 33%) in trials investigating SDD with systemic antimicrobial therapy and 1.00 (.84-1.
141 ined at the M06-2X/SDD|6-311+G(2df,p)//M06-L/SDD|6-31G(d)|MIDI!
142 pike with 4-aminopyridine induces adult-like SDD synaptic facilitation.
143  Density functional theory calculations (M06/SDD-6-311G(d,p)-IEFPCM(acetone)//B3LYP/SDD-6-31G(d)) pre
144 andardized daily dose [TSDD] and 2-year mean SDD [mSDD]) assumed constant daily exposure effects.
145      In deep sites (baseline PD > or =7 mm), SDD-40 provided significant benefits over control for me
146 breakpoints are as follows: S, > or = 17 mm; SDD, 14 to 16 mm; and R, < or = 13 mm.
147 st-procedure were similar in the SDD and non-SDD groups.
148 tients had SDD, and 118 of 190 (62%) had non-SDD.
149                  Only 1 patient from the non-SDD group had clinically significant peri-device flow (>
150                       Among placebo (but not SDD) participants, RCAL changes were associated with con
151                       Among placebo (but not SDD) participants, relative CAL changes were associated
152  including formulation and administration of SDD paste, approaches to consent and ecology monitoring.
153 re associated with the increased adoption of SDD adoption over time in the United Kingdom and determi
154 es would provide more homogenous adoption of SDD nationally.
155                          Greater adoption of SDD programs after PCI has the potential to improve pati
156                     Unit-wide application of SDD and SOD was associated with low levels of antibiotic
157                     Although the benefits of SDD therapy, such as improvement in the parameters of pe
158 (20 mg b.i.d.) alone; or 3) a combination of SDD plus LDF (combination).
159 stics play critical role in determination of SDD after PCI.
160 %) of children received at least one dose of SDD and of these, 68% commenced within the first 6 h.
161  animal-model study evaluated the effects of SDD monotherapy on the expressions of the following key
162  study was conducted to test the efficacy of SDD (20 mg doxycycline B.I.D.) in combination with SRP i
163 his study was to investigate the efficacy of SDD-40 when used as an adjunct to SRP for the treatment
164                                    Growth of SDD was mainly associated with regional characteristics,
165 mportant to the successful implementation of SDD after PCI.
166                 To evaluate the influence of SDD on 30-day readmission rates following appendectomy f
167 comparing 12 months of SOD with 12 months of SDD in 16 Dutch ICUs between August 1, 2009, and Februar
168 n the ecologic assessment, noninferiority of SDD was not confirmed for the development of new antibio
169 red patients had significantly lower odds of SDD along with higher incidence of unplanned readmission
170  In addition, we evaluated the predictors of SDD (compared with next-day discharge) and the causes of
171 tral-domain OCT (to evaluate the presence of SDD).
172 dicators for MA include baseline presence of SDD, disrupted ELM, and larger lesion area.
173                            The prevalence of SDD is strongly associated with AMD presence and severit
174 ection per the AREDS protocol, prevalence of SDD was 2% (12/610).
175                                Prevalence of SDD was 23% in subjects without AMD and 52% in subjects
176                        Overall prevalence of SDD was 32% (197/611), with 62% (122/197) affected in bo
177 lagenase and anti-inflammatory properties of SDD and not to an antimicrobial effect.
178 ere was modest increase in the proportion of SDD after PCI from 2.5% in 2009 to 7.4% in 2013 (P-trend
179 this study was to further assess the role of SDD as an adjunct to scaling and root planing (SRP) in t
180 he available evidence supports the safety of SDD in selected patients after PCI.
181 ulticenter study, the efficacy and safety of SDD were evaluated in conjunction with scaling and root
182 ns for genetic and rehabilitative studies of SDD.
183 nrolled in the ecological assessment, use of SDD was not shown to be noninferior with regard to the c
184                        The adjunctive use of SDD with SRP is more effective than SRP alone and may re
185  trends and variations in the utilization of SDD after PCI during the contemporary era.
186 I volume hospitals had higher utilization of SDD compared with their respective counterparts.
187  famous faces in 24 adults with a variety of SDD diagnoses.
188                                 Consensus on SDD detection methods is recommended to advance our know
189 of PubMed was performed for human studies on SDD PCI published in English from January 1, 1995, to Ju
190                   In subgroup analysis, only SDD significantly decreased mortality compared with cont
191          Five eyes of 3 patients showed only SDD and no drusen.
192                      Patients with drusen or SDD were significantly younger (mean 70.88 +/- 6.85, p =
193  mutations in ubiquitin-like domain (ULD) or SDD display defects in dimerization; however, a subset r
194                                     Overall, SDD subgroup membership by face recognition did not corr
195        Reduced visibility of cones overlying SDD in the AO images can be because of several possible
196                   Using the M06/6-311+G(d,p)-SDD method, various concerted transition states for the
197 ( ) = 107.9 kJ/mol; at the M06L/6-311+G(d,p)/SDD level of theory) for this S(N)2-like reaction in the
198 ognition did not correlate with a particular SDD diagnosis or subjective ratings of social impairment
199 are system has transitioned to predominantly SDD for elective percutaneous coronary intervention.
200 es (n = 118 subjects), 94 (50.5%) presenting SDD.
201 ith periodontitis were randomized to receive SDD 10 mg qd, 20 mg qd, 20 mg bid, or placebo.
202 study 3, patients were randomized to receive SDD 20 mg bid or placebo.
203 osteopenia were randomly assigned to receive SDD or placebo tablets twice daily for two years, adjunc
204 ere entered and randomly assigned to receive SDD or placebo.
205 ere treated by SRP and randomized to receive SDD-40 or placebo for 9 months with evaluations at 3, 6,
206 with chronic periodontitis randomly received SDD or placebo tablets daily for 2 years adjunctive to p
207                               More recently, SDD adjunctive to repeated mechanical debridement result
208 e findings reveal new perspectives regarding SDD efficacy because it can be partially related to proi
209                           A modified-release SDD formulation containing 40 mg doxycycline (SDD-40) to
210 ims to discuss the implications of reporting SDD interpretations for pediatric patients and recommend
211             The sensitivity of SS-OCT in RPD/SDD detection was 83%, and when using conventional imagi
212                        The difference in RPD/SDD detection with either image modality was not statist
213  When using SS-OCT imaging alone, 10% of RPD/SDD cases would be missed, and when using conventional i
214 using conventional imaging alone, 14% of RPD/SDD cases would be missed.
215                          The presence of RPD/SDD was confirmed retrospectively in 48 of 52 cases once
216   We show here that the presence of sequence SDD, a characteristic of motif C of segmented NS RNA vir
217 e L mutant, in which the conserved signature SDD motif was replaced by the amino acid residues GNN, e
218                           Compared with SOD, SDD was associated with lower rectal carriage of antibio
219            Abnormal face recognition in some SDD subjects is related to impaired perception of facial
220  zone) was observed after regression of some SDD in 5 eyes of 4 patients.
221   Reflectivity of photoreceptors surrounding SDD were assessed with AOSLO and SD OCT.
222                                          Ten SDD isolates showed mean ergosterol reductions of 38, 57
223  Our four studies assessed whether long-term SDD changes antibiotic susceptibility of the oral microf
224                                    Long-term SDD does not contribute to changes in antibiotic suscept
225 pport the therapeutic potential of long-term SDD therapy to reduce periodontal collagen breakdown and
226                      We now hypothesize that SDD may also improve biomarkers of bone loss systemicall
227                                          The SDD mediates IKKbeta dimerization, but dimerization per
228 ve disease (e.g., rheumatoid arthritis), the SDD and NSAID combination therapy synergistically suppre
229 ty was 8964 +/- 2793 cones/mm(2) between the SDD and 863 +/- 388 cones/mm(2) over the SDD, a 90.4% nu
230 atment differences were detected between the SDD and placebo treatments in either the SRP or non-SRP
231 is the reason for the disparity; and can the SDD model explain Bcd gradient formation within the expe
232 consultation to guide daptomycin use for the SDD category.
233 d 45 days post-procedure were similar in the SDD and non-SDD groups.
234 d 928/3191 (29.1%) in-hospital deaths in the SDD and standard care groups, respectively (mean differe
235                              Patients in the SDD group (n = 2791) received a 6-hourly application of
236 e AVL group after 27.6 months and 20% in the SDD group after 36.9 months.
237 0 days, 1175 of 4215 patients (27.9%) in the SDD group and 1494 of 5065 (29.5%) in the standard-care
238 ions occurred in 4.9% of the patients in the SDD group and in 6.8% of those in the standard-care grou
239 e were reported in 12 patients (0.3%) in the SDD group and in no patients in the standard-care group.
240  or = 3 mm was seen in 15.4% of sites in the SDD group compared to 10.6% of sites in the placebo grou
241 holds of change in PD, 42.9% of sites in the SDD group compared to 31.1% of sites in the placebo grou
242 = 2 mm (P < 0.01), and 15.4% of sites in the SDD group compared to 9.1% of sites in the placebo group
243            At month 9, 42.3% of sites in the SDD group demonstrated CAL gain > or = 2 mm compared to
244                              Patients in the SDD group received specific oral and gastric antimicrobi
245 only 2 pockets deepened by > or =4 mm in the SDD group versus 10 in the placebo group.
246   The spirochetal proportions present in the SDD group were significantly lower (P<0.05) than the pai
247                                       In the SDD group, nearly 40% of 237 pockets > or =7 mm were red
248 MIC > or = 16 microg/ml) for patients in the SDD group.
249  clinically and statistically greater in the SDD group.
250                                       In the SDD vs standard care groups, 23.1% vs 34.6% had new ARO
251  (PD) > or =6 mm, 72% to 76% of sites in the SDD-40 group demonstrated clinically significant PD redu
252 roup (P <0.0001); 48% to 52% of sites in the SDD-40 group demonstrated PD reductions and CAL gains >
253 l-phase memory after depressurization in the SDD-GaSe film was recognized, attributed to the screw di
254 f out-of-plane phonon-vibration modes in the SDD-GaSe film, especially at low-pressure range (< 5 GPa
255 se density of screw dislocation cores in the SDD-GaSe lattice structure plays a crucial role in these
256 8; P = 0.0001) in the placebo group, not the SDD group, and a loss of bone height (OR = 1.38; P = 0.0
257  We also performed a cluster analysis of the SDD patients.
258                        rGbeta1 is one of the SDD products that encodes a rat G-protein beta subunit.
259 able 1.7 times higher in bulk modulus of the SDD-GaSe film in comparison to bulk counterpart was obse
260 ot form these structures but are part of the SDD.
261 the SDD and 863 +/- 388 cones/mm(2) over the SDD, a 90.4% numerical reduction.
262  gradient properties are compatible with the SDD model in which Bcd is synthesized at the anterior po
263                    Reporting MICs within the SDD category suggests that treatment success is likely w
264 nd the relative frequency of LDD compared to SDD and correlates of dispersal distances.
265                  Subjects were randomized to SDD (n = 64) or a placebo (n = 64).
266   Adverse events considered to be related to SDD or standard care were reported in 12 patients (0.3%)
267 hich mutates the palm domain GDD sequence to SDD.
268 tive decontamination of the digestive tract (SDD) and selective oropharyngeal decontamination (SOD) a
269 tive Decontamination of the Digestive tract (SDD) may reduce the incidence of HCAIs and improve survi
270  patients undergoing mechanical ventilation, SDD did not result in a lower incidence of in-hospital d
271 l patients receiving mechanical ventilation, SDD, compared with standard care without SDD, did not si
272 es which continued standard care and 3 where SDD was incorporated into infection control practice for
273 w-onset AF was independently associated with SDD (8% vs. 3%) and >=MDD (25% vs. 16%); 62% of patients
274  band as seen by SD-OCT were associated with SDD but not conventional drusen.
275  was also significantly reduced in eyes with SDD (ss = -0.003, P = .007).
276 seline to 80% at the last visit in eyes with SDD and from 31% to 70% in eyes without SDD.
277 ter AMD severity and especially in eyes with SDD both at baseline and at 4 years.
278                                    Eyes with SDD have reduced rod function compared to iAMD without S
279 3.5 [10-22] minutes) but less than eyes with SDD only (40 [28-40] minutes).
280 evealed that, controlling for age, eyes with SDD presented a statistically thinner mean CT (ss = -21.
281 s/degree(2)/year, respectively, in eyes with SDD, and by -212 +/- 89, -83 +/- 37, and -27 +/- 18 cone
282 nd healthy individuals nor between iAMD with SDD and non-foveal atrophic AMD groups.
283 ound complication rate between patients with SDD and those discharged 1 or 2 days after surgery (aOR
284 in the odds of readmission for patients with SDD compared with those discharged within 2 days (adjust
285                              Of persons with SDD detected by SD OCT and confirmed by at least 1 en fa
286                                 Persons with SDD were older than those without SDD (70.6 vs. 68.7 yea
287                      Short-term therapy with SDD alone produced a significant reduction and LDF alone
288             After age adjustment, those with SDD were 3.4 times more likely to have AMD than those wi
289  flora was detected following treatment with SDD for 24 months, relative to baseline or to placebo.
290                                       Within SDD, females tended to disperse farther than males, and
291 tinal drusenoid deposits (SDD) and 3 without SDD.
292 on, SDD, compared with standard care without SDD, did not significantly reduce in-hospital mortality.
293  drusenoid deposits (SDD) vs 47 eyes without SDD, rod-mediated dark adaptation time was longer (mean
294 egree(2)/year, respectively, in eyes without SDD.
295 with SDD and from 31% to 70% in eyes without SDD.
296 educed rod function compared to iAMD without SDD and healthy eyes, but similar to eyes with non-fovea
297 at any retinal location between iAMD without SDD and healthy individuals nor between iAMD with SDD an
298 controls and intermediate AMD (iAMD) without SDD.
299 rsons with SDD were older than those without SDD (70.6 vs. 68.7 years, P = 0.0002).
300 s more likely to have AMD than those without SDD (95% confidence interval, 2.3-4.9).

 
Page Top